COLOPEG is developed by Norgine.

What development phase is COLOPEG in?

COLOPEG is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

COLOPEG

Norgine · FDA-approved active Small molecule Quality 1/100

At a glance

Generic name	COLOPEG
Sponsor	Norgine
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Colonoscopy by Videocapsuls Versus Standard Colonoscopy. Intra-individual Comparison for the Subject With a Medium or High Risk of Colorectal Cancer. (NA)
A Phase IV Study, of the Efficacy, Safety, and Acceptability of Moviprep® Versus Colopeg® in Colonoscopy Preparation (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

COLOPEG CI brief — competitive landscape report
COLOPEG updates RSS · CI watch RSS
Norgine portfolio CI